By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update NDA Filing in 2H24; Pre-NDA Meeting in 2Q24 In the second half of 2024, Tonix Pharmaceuticals Holding Corp. (NASDAQ:...
Source LinkBy David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update NDA Filing in 2H24; Pre-NDA Meeting in 2Q24 In the second half of 2024, Tonix Pharmaceuticals Holding Corp. (NASDAQ:...
Source Link
Comments